Tesamorelin Ipamorelin Dose: Blend Dosage, Timing, and Safety

A typical tesamorelin ipamorelin dose combines roughly 1 mg to 2 mg of tesamorelin with 100 mcg to 300 mcg of ipamorelin, injected subcutaneously once daily, usually at night on an empty stomach. That range is a starting framework, not a universal standard, because the right number depends on the blend ratio in the vial and on what a clinician or research protocol specifies. Tesamorelin is FDA-approved only for HIV-associated lipodystrophy, and ipamorelin is not approved for human use in the United States.

Tesamorelin and Ipamorelin Are Dosed on Two Different Scales

These two peptides are not interchangeable and they are not dosed the same way. Tesamorelin is a growth hormone-releasing hormone (GHRH) analog measured in milligrams, while ipamorelin is a selective ghrelin-receptor agonist measured in micrograms.

• Tesamorelin: the FDA label dose is 2 mg once daily by subcutaneous injection; the newer Egrifta WR formulation is 1.4 mg once daily.
• Ipamorelin: research and anecdotal protocols typically use 100 mcg to 300 mcg per injection, one to three times daily.
• Why they are stacked: they act on different receptors, so pairing them can produce a larger, more natural-looking GH pulse than either peptide alone.

Tesamorelin and ipamorelin work through different receptors, so a tesamorelin and ipamorelin dosage is usually built from two separate dose ranges rather than one combined number.

Tesamorelin Ipamorelin Dosage Chart by Blend Ratio

Most products sold as a tesamorelin ipamorelin blend lock the peptides into a fixed ratio, so the tesamorelin dose you choose automatically determines how much ipamorelin you get. The table below shows what a 2 mg tesamorelin dose delivers at the ratios that appear most often.

Blend ratio (tesamorelin : ipamorelin)	Dose for 2 mg tesamorelin	Ipamorelin delivered	Notes
12 mg : 2 mg (6:1)	2 mg	about 333 mcg	Closest match to a full tesamorelin dose plus a mid-range ipamorelin dose
8 mg : 2 mg (4:1)	2 mg	500 mcg	Ipamorelin now above most research ranges
6 mg : 2 mg (3:1)	2 mg	about 667 mcg	Requires lowering the tesamorelin dose to stay reasonable
10 mg : 5 mg (2:1)	2 mg	1,000 mcg	Ipamorelin far above typical research dosing; most users split this injection

Notice the pattern: as the ratio shifts toward ipamorelin, a full 2 mg tesamorelin dose drags the ipamorelin number upward fast. The 2x blend tesamorelin 10mg ipamorelin 5mg is the clearest example, since one 2 mg tesamorelin dose carries 1 mg of ipamorelin.

How to Calculate a Blend Dose From Your Vial

Dose math on a fixed-ratio blend takes four steps, and the same method works for any ratio.

1. Add the total peptide mass in the vial. A 12 mg tesamorelin / 2 mg ipamorelin vial contains 14 mg of powder.
2. Divide total mass by the volume of bacteriostatic water you add. Adding 3 mL gives roughly 4.67 mg per mL.
3. Divide your target tesamorelin dose by the concentration to get the draw volume. A 2 mg target equals about 0.43 mL.
4. Convert to syringe units. On a U-100 insulin syringe, 0.43 mL is 43 units, and that same draw delivers about 333 mcg of ipamorelin.

Anyone working through tesamorelin/ipamorelin 12 2mg reconstitution should double-check the ipamorelin side of the equation before injecting, because a comfortable tesamorelin volume can still carry an uncomfortable ipamorelin dose.

Tesamorelin Ipamorelin Dosage Per Day and Injection Timing

Frequency matters as much as the number on the syringe. Tesamorelin is studied and labeled as a once-daily evening injection, while ipamorelin is often used two or three times daily in research settings. A tesamorelin ipamorelin dosage per day therefore usually means one nightly injection that blends both goals, plus a decision about whether to add extra ipamorelin-only doses.

• Timing: inject on an empty stomach, ideally two or more hours after eating and about 30 minutes before the next meal.
• Night vs. day: nighttime dosing lines up with the body's largest natural GH pulse and is the most common tesamorelin ipamorelin blend protocol.
• Duration: clinical tesamorelin trials ran 26 to 52 weeks, while ipamorelin cycles in research and anecdotal use are usually shorter.

If the goal is a longer-acting GH signal rather than a single nighttime pulse, cjc-1295 ipamorelin vs tesamorelin comparisons are worth reading, because CJC-1295 stays active in the body far longer than tesamorelin does.

Blend vs. Separate Vials: Which Gives Better Dose Control

Approach	Tesamorelin dose control	Ipamorelin dose control	Practical trade-off
Fixed-ratio blend	Set by the ratio	Locked to tesamorelin	One injection, least flexibility
Separate tesamorelin and ipamorelin vials	Exact (1-2 mg)	Exact (100-300 mcg)	Two draws, higher cost and more supplies
Ipamorelin alone	None	Exact	No visceral fat effect from tesamorelin

Separate vials give the cleanest tesamorelin ipamorelin stack dosage, because each peptide can be adjusted independently instead of being forced into one syringe. Blends are cheaper and simpler, but they trade away that control.

Safety, Side Effects, and Legal Status

Neither peptide is a consumer supplement, and neither should be started without medical supervision.

• Tesamorelin's FDA-approved use is limited to HIV-associated lipodystrophy, and it is contraindicated during pregnancy and in people with active malignancy.
• Reported tesamorelin side effects include injection-site reactions, joint and muscle pain, fluid retention, and rises in IGF-1; it can also affect blood sugar.
• Ipamorelin has limited human safety data and is widely sold as a research chemical that is not for human consumption.
• Underground blends are often underdosed, mislabeled, or contaminated, which makes reported results hard to compare.

Anyone considering a tesamorelin ipamorelin blend dosage should talk with a licensed healthcare professional and get baseline IGF-1, glucose, and liver labs before and during use.

Why Reported Tesamorelin Ipamorelin Dosages Vary So Much

Search tesamorelin ipamorelin dosage reddit and you will find numbers that differ by a factor of ten. Most of that spread comes from unit confusion rather than real disagreement: people mix up milligrams and micrograms, syringe units and milliliters, or a whole-vial dose and a per-injection dose. Blend ratios also vary between vendors, so two people describing "2 mg" may be injecting very different amounts of ipamorelin.

People who want fat-loss effects without the GH signal sometimes look at other options, which is why questions about aod 9604 with tesamorelin come up. Comparing an aod 9604 peptide dose with a tesamorelin dose is a separate calculation, since AOD-9604 is not a growth hormone secretagogue at all.

COMMON QUESTIONS

Frequently Asked Questions

What is a typical tesamorelin ipamorelin dose per day?

Most protocols pair about 1 mg to 2 mg of tesamorelin with 100 mcg to 300 mcg of ipamorelin in a single nightly subcutaneous injection. Tesamorelin's FDA label calls for 2 mg once daily, and ipamorelin research doses generally top out around 300 mcg per injection. Anyone using a fixed-ratio blend should check how much ipamorelin a full 2 mg tesamorelin dose actually delivers.

How do I dose a 2x blend of tesamorelin 10 mg and ipamorelin 5 mg?

A 2:1 blend delivers 1 mg (1,000 mcg) of ipamorelin for every 2 mg of tesamorelin, which is well above typical ipamorelin research dosing. Most people either lower the tesamorelin dose and accept a smaller GH stimulus or split the injection. Because the ratio is fixed, you cannot adjust one peptide without changing the other.

Is tesamorelin ipamorelin FDA-approved?

Tesamorelin is FDA-approved only as Egrifta and Egrifta WR for HIV-associated lipodystrophy, not for general weight loss or anti-aging. Ipamorelin is not FDA-approved for any human use and is sold as a research chemical. Blends of the two are not approved products, so purity and actual dosing are unverified.